首页 | 本学科首页   官方微博 | 高级检索  
相似文献
 共查询到18条相似文献,搜索用时 171 毫秒
1.
目的 了解鲍曼不动杆菌的耐药性和整合子表达及耐药基因携带情况.方法 收集100株鲍曼不动杆菌,以VITEK-64系统鉴定细菌,并进行14种抗生素药敏试验,通过PCR法检测Ⅰ、Ⅱ、Ⅲ类整合酶基因(intI1、2、3)及Ⅰ类整合子可变区基因盒,并对基因盒测序.结果 除阿米卡星和头孢哌酮/舒巴坦,鲍曼不动杆菌对其他12种抗菌药物耐药率均大于60.0%,多重耐药率为88.0%.鲍曼不动杆菌整合酶基因阳性率为64.0%,均为intI1,整合子阳性菌株对多数药物的耐药率显著高于整合子阴性者(P<0.05).intI1阳性菌株中,84.4% (54/64)扩增出整合子可变区,检出3种耐药基因盒组合形式:aac(6’)-Ib-cr-arr-3-dfrA27 14株、aacA4-catB8-aadA1 24株、aacC1-orfA-orfB-aadA1 16株.结论 临床分离的鲍曼不动杆菌多重耐药与Ⅰ类整合子表达有关.Ⅰ类整合子主要携带早期使用的氨基糖苷类抗菌药、甲氧苄啶和氯霉素耐药基因.  相似文献   

2.
【摘 要】 目的 研究整合子参与鲍曼不动杆菌耐药的分子机制。结果 收集2008年1月至2011年12月瑞安市中医院临床分离的200株鲍曼不动杆菌,采用K-B法进行体外药敏试验,采用聚合酶链式反应进行整合子整合酶基因的检测;整合子可变区扩增、克隆、测序,分析整合子基因结构。结果 59.0%的医院感染鲍曼不动杆菌Ⅰ类整合子阳性,未检测出Ⅱ、Ⅲ类整合子;编码对氨基糖苷类、磺胺类抗菌药物和氯霉素耐药的基因;整合子阳性组多药耐药菌均明显高于阴性组。结论 Ⅰ类整合子在医院感染鲍曼不动杆菌中广泛分布,可通过质粒在不同菌属间水平传播,在耐药基因传播中起重要作用,应引起临床足够的重视。  相似文献   

3.
目的考察临床分离的鲍曼不动杆菌的耐药性并对泛耐药菌株的耐药基因进行检测。方法用纸片扩散法对60株临床分离鲍曼不动杆菌进行药物敏感试验,并用PCR法检测8株泛耐药菌株携带7种耐药基因OXA-51、OXA-23、OXA-24、OXA-58、aac(3)-Ⅰ、gyr A、abe M的情况。结果所分离的鲍曼不动杆菌对临床常用的β-内酰胺类抗生素、氨基糖苷类抗生素、四环素类抗生素、磺胺类抗菌药及喹诺酮类抗菌药均产生耐药性;在8株泛耐药鲍曼不动杆菌中OXA-51、OXA-23、OXA-58、gyr A、abe M基因检测均全部呈阳性;OXA-24基因检测均呈阴性;aac(3)-I基因检测有5株呈阳性,3株呈阴性。结论鲍曼不动杆菌耐药情况严重,其耐药机制与多种耐药基因密切相关。  相似文献   

4.
目的了解鲍曼不动杆菌的耐药情况,并检测耐碳青霉烯类鲍曼不动杆菌的耐药基因,为指导临床合理用药、控制院内感染提供依据。方法利用K-B法检测45株鲍曼不动杆菌临床分离株的耐药情况,通过改良Hodge试验、Carba NP试验和EDTA协同试验对多重耐药鲍曼不动杆菌的碳青霉烯酶进行表型检测,并采用PCR技术检测鲍曼不动杆菌携带OXA-23和NDM-1型耐药基因的情况。结果 45株鲍曼不动杆菌临床分离株中共筛出42株多重耐药菌株;利用改良Hodge试验和Carba NP试验检出36株碳青霉烯酶阳性菌株;采用PCR扩增出OXA-23,未扩增出NDM-1。结论鲍曼不动杆菌耐药情况严重,且耐药基因OXA-23携带率高,治疗时应根据药敏试验结果合理用药。  相似文献   

5.
目的调查肺炎链球菌整合子携带状况,并分析整合子与其耐药性的相关性。方法用K-B纸片扩散法和E试验法检测42株肺炎链球菌(SPN)对8种抗生素的耐药状况,并采用多重PCR对其进行Ⅰ、Ⅱ、Ⅲ类整合子分析。结果 42株SPN对四环素、红霉素、复方新诺明和青霉素耐药率分别为90.5%、73.4%、59.5%和40.4%,而对万古霉素、利福平则呈高敏感性(100%);42株SPN共检测出整合子20例(47.6%),其中Ⅰ类整合子18例,Ⅱ类整合子1例,Ⅰ、Ⅱ类整合子混合携带1例,未检测出Ⅲ类整合子菌株;整合子阳性组对多种抗生素(大于3种)的不敏感率明显高于整合子阴性组(阳性组占88.7%,阴性组占25.2%),差异具有统计学意义(P0.05),其中以青霉素类、喹诺酮类更为明显(P0.001)。结论整合子与细菌耐药及多重耐药密切相关。  相似文献   

6.
【目的】研究I型整合子的结构特征,探讨其与细菌多重耐药之间的相关性。【方法】收集2008年至2009年广州呼吸疾病研究所上呼吸道分离的187株鲍曼不动杆菌,应用K-B纸片扩散法检测耐药性,采用聚合酶链式反应进行I型整合子整合酶基因的检测;扩增整合子的可变区,应用DNA测序技术分析I型整合子基因结构。【结果】I型整合子的阳性率达53.4%。共七种1型整合子基因盒被鉴定,其中首次发现报道一种新的整合子(GenBank:HQ322622)。可变区主要编码氨基糖苷类药物的耐药基因。20种抗菌素耐药的结果均表明携带Ⅰ型整合子的鲍曼不动杆菌耐药率较不携带I型整合子的鲍曼不动杆菌的耐药率明显增高。整合子与鲍曼不动杆菌的多重耐药表型具有密切相关性。【结论】I类整合子相关耐药基因在本院临床分离鲍曼不动杆菌中分布较广泛。整合子在鲍曼不动杆菌耐药性的形成和播散中具有重要作用。  相似文献   

7.
了解氨基糖苷类修饰酶、16S rRNA甲基化酶基因在多重耐药鲍曼不动杆菌中的流行情况。收集2014年12月至2015年3月厦门大学附属成功医院住院患者临床分离的多重耐药鲍曼不动杆菌共28株,采用VIKET Compact 2全自动细菌鉴定系统进行细菌鉴定,应用纸片扩散法(K-B法)检测鲍曼不动杆菌对抗菌药物的耐药性,采用聚合酶链反应(PCR)法检测氨基糖苷类修饰酶、16S rRNA甲基化酶基因。结果显示,多重耐药鲍曼不动杆菌除对头孢哌酮/舒巴坦耐药率为21.4%外,对其他所测药物耐药率均50%,本组28株多重耐药鲍曼不动杆菌共检出5种氨基糖苷类修饰酶基因aac(3)-Ⅰ、aac(3)-Ⅱ、aac(6')-Ⅰb、ant(3")-Ⅰ、aph(3')-Ⅰ和1种16S rRNA甲基化酶基因arm A,阳性率分别为85.7%(24株)、7.14%(2株)、67.8%(19株)、92.9%(26株)、53.6%(15株)和82.1%(23株)。氨基糖苷类修饰酶、16S rRNA甲基化酶耐药基因是多重耐药鲍曼不动杆菌对氨基糖苷类耐药的重要原因。  相似文献   

8.
摘要:【目的】研究鲍曼不动杆菌持留菌的特征,分析鲍曼不动杆菌Ⅱ型毒素-抗毒素(TA)系统的多样性及分布,探讨TA系统与持留菌形成的潜在关联。【方法】采用分属于6 大类中的6种不同抗生素分别筛选的方法分离并定量鲍曼不动杆菌的持留菌;应用PSI-BLAST及TBLASTN程序分析721株鲍曼不动杆菌中的Ⅱ型TA系统;通过聚合酶链式反应(PCR)方法检测44株临床多重耐药(MDR)的鲍曼不动杆菌中5个Ⅱ型TA系统的分布。【结果】我们发现不同抗生素处理得到的鲍曼不动杆菌持留菌的数量并不相同;对多数抗生素而言,浓度越高,得到的持留菌数量越少;处于生长平台期的菌株中相比对数期含有更多的持留菌;多粘菌素B及妥布霉素均具有杀灭部分持留菌的能力;鲍曼不动杆菌所有菌株中均含有Ⅱ型TA系统,HTH/GNAT类型在菌株中分布最为广泛;所有700余株鲍曼不动杆菌基因组中共含有15个潜在的Ⅱ型TA系统;三类普遍存在于已知基因组中的明确功能的Ⅱ型TA系统在临床多重耐药菌株中同样分布广泛,且HigB/HigA的表达量在标准株的持留菌中显著增高。【结论】鲍曼不动杆菌的持留菌水平与菌株的生长状态、抗生素的种类及浓度密切相关。Ⅱ型TA系统在鲍曼不动杆菌已知基因组和临床多重耐药菌株中普遍存在,其中,HTH/GNAT、GP49/Cro(HigB/HigA)及DUF497/COG3514三种类型的Ⅱ型TA系统可能在鲍曼不动杆菌持留菌的形成中扮演重要角色。  相似文献   

9.
目的 了解台州地区碳青霉烯类耐药鲍曼不动杆菌的耐药性、碳青霉烯酶基因型以及同源性.方法 63株碳青霉烯类耐药鲍曼不动杆菌经VITEK2 Compact进行细菌鉴定及药敏分析,用K-B法复核药敏结果,采用多重PCR扩增分析碳青霉烯酶的基因型;采用脉冲场凝胶电泳(pulsed field gel electrophoresis,PFGE)分析其同源性.结果 63株菌株为多重耐药菌株,除多粘菌素、阿米卡星、头孢哌酮/舒巴坦外,对其他常用抗生素的耐药率均在70%以上.63株菌株检测出OXA-51基因60株(95.2%),OXA-23基因58株(92.1%),两个基因同时存在的有58株(92.1%).PFGE结果显示碳青霉烯类鲍曼不动杆菌主要分为5个克隆型,其中A、B两个为主型.结论 产OXA酶是台州地区耐碳青霉烯类鲍曼不动杆菌的主要耐药机制之一,其中OXA-23是主要的基因型.  相似文献   

10.
I类整合子与产ESBLs肺炎克雷伯菌多重耐药关系的研究   总被引:1,自引:0,他引:1  
目的了解产ESBLs肺炎克雷伯菌的整合子存在状况。方法用PCR方法扩增Ⅰ类整合酶基因,经电泳后检测扩增产物。结果72株产ESBLs肺炎克雷伯菌中检测出Ⅰ类整合子67株,检出率为93.0%,Ⅰ类整合子阳性菌对氨基糖苷类、喹诺酮类及头孢菌素类药物表现出较高的耐药,其多重耐药率明显高于Ⅰ类整合子阴性菌株(P〈0.05)。结论Ⅰ类整合子广泛地存在产ESBLs肺炎克雷伯菌中,Ⅰ类整合子对细菌多重耐药性的产生和传播起着重要作用。  相似文献   

11.
AIM: To detect the integron-positive strains among nosocomial Acinetobacter spp. and to determine their relationship on the genotype level. MATERIALS AND METHODS: Amplification by polymerase chain reaction using primers specific to sequences of the class 1 and 2 intergrons on the genomic DNA template followed by restriction fragments length polymorphism analysis as well as RAPD-genotyping of the integron-positive strains were performed. RESULTS: Fact of spreading of Acinetobacter baumanii strain containing class 1 integron in medical centers was established. The composition of the integron's gene cassettes was analogous to worldwide (including epidemic) types. CONCLUSION: Molecular genetic analysis of the mobilized structures (integrons) under the standardization of used approaches are suitable for the surveillance for circulation of epidemic strains of nosocomial pathogens.  相似文献   

12.
目的了解临床分离变形杆菌中1、2类整合子的流行现状及其耐药性。方法PCR扩增146株变形杆菌中1、2类整合酶基因,M-H肉汤稀释法检测146株变形杆菌的药敏情况。结果1类整合子检出率为36.9%(54/146),2类整合子检出率为38.4%(56/146),同时携带1、2类整合子的检出率为18.5%(27/146)。结论1、2类整合子在变形杆菌感染临床分离株中所占比例已相当高,1、2类整合子与变形杆菌的多重耐药具有相关性。  相似文献   

13.
The genotype structure and silver sulfadiazine (SDS) resistance of a number of Acinetobacter baumanii strains that circulated for a prolonged period of time in burn UCUs were studied. The most resistant strain (SDS MIC 50 mcg/ml) contained a class 1 integron with the gene of sulfonamides resistance (sul1) in its genome. Possible reasons for selection of the multiple resistance among Acinetobacter spp. in burn units are discussed.  相似文献   

14.
目的检测I类整合子在肺炎克雷伯菌临床分离株中的分布,分析整合子对细菌耐药性的影响。方法采用K—B纸片扩散法对127株肺炎克雷伯菌临床分离株进行药敏试验;并用WHONET5.6软件分析菌株药敏情况;采用聚合酶链反应(PCR)分析127株肺炎克雷伯菌株的I类整合子。并对I类整合子阳性株与阴性株的耐药性进行对比分析。结果127株菌中有53株(41.70%)含有I类整合子,I类整合子阳性菌株对氨基糖苷类、喹诺酮类及大多数B一内酰胺类的耐药率高于整合子阴性的菌株。结论I类整合子在肺炎克雷伯菌临床分离株存在较广,含有I类整合子的肺炎克雷伯菌更易获得耐药性。  相似文献   

15.
Integrons are associated with a variety of gene cassettes, which confer resistance to multiple classes of antibacterial drugs. In this study we tested the frequency of class 1 and 2 integrons among multidrug-resistant Acinetobacter baumannii (MDRAB) clinical isolates. One hundred clinical isolates of A. baumannii were screened for carriage of class 1 and 2 integrons by PCR method. Results showed that seventy four (92.5%) of 80 MDRAB carried class 1 integron. Integron-positive isolates were statistically more resistant to aminoglycoside, quinolone and beta-lactam compounds except for cefepime. This is the first report of class 1 integrons in MDRAB isolates in northwest Iran.  相似文献   

16.
The aim of this study was to investigate the incidence of and resistance gene content of class 1 integrons among enteropathogenic Escherichia coli (EPEC) and non-EPEC and to investigate intraspecies genetic diversity of EPEC strains isolated from children with diarrhea in Iran. Twenty-eight EPEC and 16 non-EPEC strains isolated from children with diarrhea were tested for the presence of a class 1 integron associated integrase gene (int1). Sequence analysis was performed to identify the resistance gene content of integrons. Genetic diversity and cluster analysis of EPEC isolates were also investigated using enterobacterial repetitive intergenic concensus-polymerase chain reaction (ERIC-PCR) fingerprinting. Twenty-three (82%) EPEC isolates and 11 (68.7%) non-EPEC isolates harbored the int1 gene specific to the conserved integrase region of class 1 integrons. Sequence analysis revealed the dominance of dfrA and aadA gene cassettes among the isolates of both groups. ERIC-PCR fingerprinting of EPEC isolates revealed a high diversity among these isolates. The widespread distribution of 2 resistance gene families (dfrA and aadA) among both groups of EPEC and non-EPEC isolates indicates the significance of integrons in antibiotic resistance transfer among these bacteria. Furthermore, clonal diversity of EPEC isolates harbouring a class 1 integron also suggests the circulation of these mobile elements among a diverse population of EPEC in this country.  相似文献   

17.
《Microbiological research》2014,169(11):811-816
The class 1 integron is an important driver of the nosocomial dissemination of multidrug-resistant (MDR) bacteria, such as Acinetobacters. In this study, we characterized the gene cassette arrays of class 1 integrons in Acinetobacter baumannii, where the detailed structure of these integrons for 38 clinical strains was analyzed. The results showed that there are three types of gene cassette arrays that are carried by different class 1 integrons, among them the aac(6)-IId-catB8-aadA1 array was the most prevalent. For detailed analysis of the integron structure, whole genome sequencing was carried out on strain AB16, and it was found that a single integron on its chromosome has a partial Tn21 transposon in its 5′ flanking region and two complete copies of the insertion element IS26 in both the 5′ and 3′ flanking regions, indicating that the integron could be acquired by horizontal gene transfer. Furthermore, there is one resistance island AbaR22, one bla gene containing a transposon, four intrinsic resistant genes and one efflux pump that together confer six types of antibiotic resistance.  相似文献   

18.
The antimicrobial resistance and the character of integrons were determined in 58 Shigella flexneri strains isolated from China. All isolates were multi-drug resistant and found to carry integrons of class 1 (94.8%), class 2 (100%), or both (94.8%). No intI3 was detected. The typical class 1 integrons were found in conjugative plasmids and could be transferred to the recipient E. coli DH5α. The gene cassettes of typical class 1 integrons dfrA17-aadA5 and dfrA12-orfF-aadA2 were detected in 54 strains (93.1%) and 1 strain, respectively. Atypical class 1 integrons located on the chromosome with gene cassettes bla (oxa-30)-aadA1 were detected in 55 isolates (94.8%). All the intI2 positive isolates carried gene cassettes dfrA1-sat1-aadA1. To our knowledge, this is the first report that atypical and typical class 1 integrons coexisted with class 2 integron in multi-drug resistant S. flexneri strains.  相似文献   

设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号